Table 1

Poor prognostic factors in relapsed or refractory Hodgkin lymphoma

Patient groupFactor
Relapsed Time to relapse < 1 year18,21-24  
 Stage III-IV (IV: Lohri, Martin)18,19,21,22,24  
 Anemia18  
 B symptoms21,24  
 Poor performance status23  
Refractory Poor performance status17,23  
 Age > 50 y17  
 Failure to attain a temporary remission17  
 B symptoms21  
 Stage III-IV (IV: Martin)19,21  
ASCT Previously untreated relapse23  
 Response to chemotherapy19  
 Low serum albumin25  
 Anemia25  
 Age25  
 Lymphocytopenia25  
 B symptoms26  
 Extranodal disease26  
 Time to relapse < 1 year26  
 Disease status at ASCT20  
 Disease relapse in previous radiation field20  
Patient groupFactor
Relapsed Time to relapse < 1 year18,21-24  
 Stage III-IV (IV: Lohri, Martin)18,19,21,22,24  
 Anemia18  
 B symptoms21,24  
 Poor performance status23  
Refractory Poor performance status17,23  
 Age > 50 y17  
 Failure to attain a temporary remission17  
 B symptoms21  
 Stage III-IV (IV: Martin)19,21  
ASCT Previously untreated relapse23  
 Response to chemotherapy19  
 Low serum albumin25  
 Anemia25  
 Age25  
 Lymphocytopenia25  
 B symptoms26  
 Extranodal disease26  
 Time to relapse < 1 year26  
 Disease status at ASCT20  
 Disease relapse in previous radiation field20  

ASCT indicates autologous stem cell transplant.

Close Modal

or Create an Account

Close Modal
Close Modal